What is the equity of Austar Lifesciences this year?
Austar Lifesciences has equity of 773.01 M CNY this year.
Austar Lifesciences Equity 2024
Austar Lifesciences Equity
773.01 M CNY
Ticker
6118.HK
ISIN
KYG0632L1023
In 2024, Austar Lifesciences's equity was 773.01 M CNY, a -13.82% increase from the 896.94 M CNY equity in the previous year.
Austar Lifesciences Aktienanalyse
What does Austar Lifesciences do?
Austar Lifesciences Ltd is an Indian manufacturer of pharmaceutical products and medical devices. The company was founded in 2003 by Mr. Sudhir Taneja and is headquartered in the city of Mohali in the state of Punjab. Since its inception, the company has continuously evolved and is now a leading brand in the Indian healthcare market. Austar Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Austar Lifesciences's Equity
Austar Lifesciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Austar Lifesciences's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Austar Lifesciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Austar Lifesciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Austar Lifesciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Austar Lifesciences stock
What was the equity of Austar Lifesciences compared to the previous year?
The equity of Austar Lifesciences has increased/decreased by -13.82% decreased compared to the previous year.
What impact does a high equity have on investors of Austar Lifesciences?
A high equity is advantageous for investors of Austar Lifesciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Austar Lifesciences?
A low equity can be a risk for investors of Austar Lifesciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Austar Lifesciences affect the company?
An increase in equity of Austar Lifesciences can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Austar Lifesciences affect the company?
A reduction in equity of Austar Lifesciences can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Austar Lifesciences?
Some factors that can affect the equity of Austar Lifesciences include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Austar Lifesciences so important for investors?
The equity of Austar Lifesciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Austar Lifesciences take to change the equity?
To change equity, Austar Lifesciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Austar Lifesciences pay?
Over the past 12 months, Austar Lifesciences paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 7.51 %. For the coming 12 months, Austar Lifesciences is expected to pay a dividend of 0 CNY.
What is the dividend yield of Austar Lifesciences?
The current dividend yield of Austar Lifesciences is 7.51 %.
When does Austar Lifesciences pay dividends?
Austar Lifesciences pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Austar Lifesciences?
Austar Lifesciences paid dividends every year for the past 0 years.
What is the dividend of Austar Lifesciences?
For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.
In which sector is Austar Lifesciences located?
Austar Lifesciences is assigned to the 'Health' sector.
Wann musste ich die Aktien von Austar Lifesciences kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Austar Lifesciences from 6/26/2015 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 5/19/2015.
When did Austar Lifesciences pay the last dividend?
The last dividend was paid out on 6/26/2015.
What was the dividend of Austar Lifesciences in the year 2023?
In the year 2023, Austar Lifesciences distributed 0 CNY as dividends.
In which currency does Austar Lifesciences pay out the dividend?
The dividends of Austar Lifesciences are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Austar Lifesciences
Our stock analysis for Austar Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Austar Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Austar Lifesciences Revenue
- Austar Lifesciences Net Income
- Austar Lifesciences P/E
- Austar Lifesciences P/S
- Austar Lifesciences EBIT
- Austar Lifesciences Dividend
- Austar Lifesciences Stocks
- Austar Lifesciences Market capitalization
- Austar Lifesciences Debt
- Austar Lifesciences Liabilities
- Austar Lifesciences Equity
- Austar Lifesciences AAQS
- Austar Lifesciences Employees
- Austar Lifesciences ROE
- Austar Lifesciences ROA
- Austar Lifesciences ROCE
